Lipid Metabolism in COVID-19 Severe Pneumonia Compared With Severe Pneumonia Caused by Other Pathogen — COVIDOLIP  

COVID-19 Severe Pneumonia Clinical Trial

Official title: Lipid Metabolism in COVID-19 Severe Pneumonia Compared With Severe Pneumonia Caused by Other Pathogen

Status Completed

Clinical Trial Summary

SARS-COV 2 infection might be responsible for sever pneumonia. Obesity seems to be a risk factor for severe SARS-COV 2 pneumonia. Lipid metabolism alteration are described with both obesity and sepsis. The aim of the present study was to describe association between lipid metabolism, obesity, sepsis inflammation and clinical outcome in COVID-19 patient with severe pneumonia compared with severe pneumonia caused by other pathogenes.

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• COVID-19 Severe Pneumonia
• Pneumonia
• Severe Pneumonia Due to Other Pathogene

• NCT number: NCT04435223
• Study type: Observational
• Source: Centre Hospitalier Universitaire Dijon
• Status: Completed
• Start date: April 7, 2020
• Completion date: May 7, 2020